Category: Q&A

Q&A with Dr. Lisa Butterfield, PhD: Cancer Vaccines & Adoptive Cell Transfer

Dr. Lisa Butterfield, PhD recently joined the Parker Institute for Cancer Immunotherapy as Vice President focusing on cell therapies while she continues her independent cancer vaccine research as an Adjunct Professor of Microbiology and Immunology at the University of California,...

Q&A with Dr. Juliane Nguyen: Exosome Profiling with miRNA and Biotech’s Next Breakthrough

Dr. Juliane Nguyen is a professor in the Department of Pharmaceutical Sciences at the University of Buffalo. Her Therapeutic Biomaterials Laboratory investigates using exosomes and other nanoscale carriers for the treatment of diseases including cancer and ischemic heart disease. NanoString...

Q&A with Darragh Duffy, Ph.D. – Understanding the Healthy Human Immune Response with the LabEx Milieu Interieur Project

Darragh Duffy, Ph.D., is the Scientific Manager of the LabEx Milieu Interieur project at the Institut Pasteur in Paris, France. This ambitious program started in 2011 with the mission to understand the genetic and environmental contributions to healthy immune responses and...

Q&A with Dr. Stefan Prokop – Alzheimer’s: From the Amyloid Hypothesis to the Cellular Phase and Beyond

Stefan Prokop, MD, is a Neuropathologist and Research Fellow at the University of Pennsylvania School of Medicine. His work is focused on Alzheimer’s Disease (AD) with a specific interest in the role of the immune system in AD pathogenesis and...

Q&A with Dr. Nick Reder: New Frontiers in Pathology with Digital Spatial Profiling and Light Sheet Microscopy

Dr. Nick Reder, MD, MPH, currently works at the Department of Pathology at the University of Washington in Seattle. Part of his time is spent in collaboration with mechanical engineers at UW developing ways to apply light sheet microscopy to...